Skip to content

FL3X Study: An Adaptive Intervention to Improve Outcomes for Youth With Type 1 Diabetes (FL3X)

FL3X: An Adaptive Intervention to Improve Outcomes for Youth With Type 1 Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01286350
Acronym
FL3X
Enrollment
258
Registered
2011-01-31
Start date
2014-05-31
Completion date
2018-01-31
Last updated
2021-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes

Keywords

motivational interviewing, problem solving skills training, family communication, social support, adolescents

Brief summary

The purpose of this study is to see if a behavioral intervention for adolescents with type 1 diabetes will improve adherence to T1D self-management activities and improve diabetes outcomes. We expect the intervention to improve diabetes outcomes when compared to usual care.

Detailed description

The FL3X Adaptive Intervention is designed to increase adherence to T1D self-management including medical management (blood sugar testing and insulin dosing), diet, and physical activity. FL3X relies on MI, and problem-solving skills training (PSST) as the basis for the counseling strategy, and creates a coherent integration across three key components of 1) behavior family systems therapy focused on family communications and teamwork; 2) individualized diabetes education in response to knowledge gaps relevant to behavioral goal attainment; and 3) use of currently available communications technology to support behavioral goal attainment through participant-defined reminders and motivational boosters, and/or peer support. All FL3X intervention participants will receive FL3X-Basic, which is the initial 3-month intervention that includes 4 sessions (40-60 min), supplemented with short additional contacts (via text, email, or web-based communication) as needed. Thereafter, applying principles of adaptive interventions, based on a decision rule using A1c values measured at defined intervals, participants are iteratively assigned to FL3X-Check-in or FL3X-Regular, both of which continue with MI and PSST for the underlying counseling strategy. In FL3X-Check-in, participants who are doing well (responders) will receive minimal ongoing support to reinforce successful strategies through brief monthly touch-base contacts. In FL3X-Regular, those who are Regular-responders will have a minimum of 3-4 in-person full-length sessions (40-60 min) over each 6-month interval, with additional brief contacts as needed (e.g., text, voice, or internet). FL3X participants randomized to the control group will receive usual care.

Interventions

BEHAVIORALFL3X: Flexible Lifestyle Empowering Change

The FL3X Adaptive Intervention is designed to increase adherence to T1D self-management including medical management (blood sugar testing and insulin dosing), diet, and physical activity. FL3X relies on MI, and problem-solving skills training (PSST) as the basis for the counseling strategy, and creates a coherent integration across three key components of 1) behavior family systems therapy focused on family communications and teamwork; 2) individualized diabetes education in response to knowledge gaps relevant to behavioral goal attainment; and 3) use of currently available communications technology to support behavioral goal attainment through participant-defined reminders and motivational boosters, and/or peer support.

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
Children's Hospital Medical Center, Cincinnati
CollaboratorOTHER
University of Colorado, Denver
CollaboratorOTHER
University of Washington
CollaboratorOTHER
Nemours Children's Clinic
CollaboratorOTHER
University of Pittsburgh
CollaboratorOTHER
University of North Carolina, Chapel Hill
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
13 Years to 16 Years
Healthy volunteers
No

Inclusion criteria

* type 1 diabetes with duration at least 12 months * between ages 12-16 years at registration * poor glycemic control (A1c 8.0-13.0%) * parent/guardian willing to also participate * not planning on moving in the following 18 months

Exclusion criteria

* pregnant (if female) * diabetes type 2 or gestational * Pre-existing systemic chronic disease (drug abuse, cancer, certain psychiatric conditions)

Design outcomes

Primary

MeasureTime frameDescription
Hemoglobin A1c0, 3, 6, 12, 18, 24, 30 monthsHbA1c will be measured to determine impact on glucose control

Secondary

MeasureTime frameDescription
Motivation0, 3, 6, 12, 18, 24, 30 monthsMotivation related to diabetes care will be assessed
Problem solving skills0, 3, 6, 12, 18, 24, 30 monthsAssess use of problem solving skills relative to diabetes care
Hypoglycemia0, 6, 18 moMonitoring low blood sugar from continuous glucose monitoring
Risk factors for diabetes complications0, 3, 6, 12, 18, 24, 30 monthsAssess variables related to diabetes complications
Health-related quality of life0, 3, 6, 12, 18, 24, 30 monthsAssess health-related quality of life
Diabetes self-management behaviors0, 3, 6, 12, 18, 24, 30 monthsAssess use of diabetes self-management behaviors

Other

MeasureTime frameDescription
Cost of intervention delivery0-30 monthsThe study will evaluate cost to deliver intervention compared to usual care.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026